Two Interpretations of Drug Trial Data
Bluestone, Charles D.
LANCET 2(8661): 507-508, 26 August 1989
Showing items related by title, author, creator and subject.
Confidentiality Laws and Secrecy in Medical Research: Improving Public Access to Data on Drug Safety. Concealing Clinical Trial Data From Public Scrutiny Has Implications for Americans' Health Kesselheim, Aaron S.; Mello, Michelle M. (2007-03)
The Financing of Drug Trials by Pharmaceutical Companies and Its Consequences: Part 2: A Qualitative, Systematic Review of the Literature on Possible Influences on Authorship, Access to Trial Data, and Trial Registration and Publication Schott, Gisela; Pachl, Henry; Limbach, Ulrich; Gundert-Remy, Ursula; Lieb, Klaus; Ludwig, Wolf-Dieter (2010-04)In recent years, a number of studies have shown that clinical drug trials financed by pharmaceutical companies yield favorable results for company products more often than independent trials do. Moreover, pharmaceutical ...